Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Science Signaling
|
March 28, 2023
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies
Zacary P Germon, Jonathan R Sillar, Abdul Mannan, et al.
Cell Reports
|
June 13, 2026
MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilities
Taylor A Gatesman, Srinidhi Varadharajan, Brenden J Johnson, et al.
Cancer Discovery
|
October 19, 2022
Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety
Nicholas A Vitanza, Ashley L Wilson, Wenjun Huang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2025
Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Sabine Mueller, Mariella G Filbin, et al.
Nature Medicine
|
January 8, 2025
Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial
Nicholas A Vitanza, Rebecca Ronsley, Michelle Choe, et al.
Nature Genetics
|
December 5, 2022
The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location
Ilon Liu, Li Jiang, Erik R Samuelsson, et al.
Cancer Research
|
May 5, 2023
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma
Evangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Cancer Research
|
May 17, 2023
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
Evangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Cancer Cell
|
March 31, 2023
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities
Claire Xin Sun, Paul Daniel, Gabrielle Bradshaw, et al.
The Journal of Clinical Investigation
|
February 6, 2024
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma
Ryan J Duchatel, Evangeline R Jackson, Sarah G Parackal, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Science Signaling
|
March 28, 2023
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies
Zacary P Germon, Jonathan R Sillar, Abdul Mannan, et al.
Cell Reports
|
June 13, 2026
MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilities
Taylor A Gatesman, Srinidhi Varadharajan, Brenden J Johnson, et al.
Cancer Discovery
|
October 19, 2022
Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety
Nicholas A Vitanza, Ashley L Wilson, Wenjun Huang, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 24, 2025
Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Sabine Mueller, Mariella G Filbin, et al.
Nature Medicine
|
January 8, 2025
Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial
Nicholas A Vitanza, Rebecca Ronsley, Michelle Choe, et al.
Nature Genetics
|
December 5, 2022
The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location
Ilon Liu, Li Jiang, Erik R Samuelsson, et al.
Cancer Research
|
May 5, 2023
ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma
Evangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Cancer Research
|
May 17, 2023
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
Evangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, et al.
Cancer Cell
|
March 31, 2023
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities
Claire Xin Sun, Paul Daniel, Gabrielle Bradshaw, et al.
The Journal of Clinical Investigation
|
February 6, 2024
PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma
Ryan J Duchatel, Evangeline R Jackson, Sarah G Parackal, et al.
Page
of 10